systemic sclerosis spectrum disorder-related RPRaynaud’s phenomenon (RP)sildenafilphosphodiesterase inhibitor
…aimed to complete validation.Material and Methods Patients with systemic sclerosis spectrum disorder-related RP, beginning a phosphodiesterase inhibitor attended on three occa…